@net_connectinfo NET CONNECT powered by COR2ED
NET CONNECT powered by COR2ED posts on X about study, education, dr, supported the most. They currently have [-----] followers and [---] posts still getting attention that total [------] engagements in the last [--] hours.
Engagements: [------] #
- [--] Week [------] +35,348%
- [--] Month [------] +17,369%
- [--] Year [-------] -92%
Mentions: [--] #
- [--] Week [--] +4,000%
- [--] Month [--] +950%
- [--] Year [--] no change
Followers: [-----] #
- [--] Week [-----] +0.29%
- [--] Month [-----] +1.20%
- [--] Year [-----] +20%
CreatorRank: [-------] #
Social Influence
Social category influence nba 20.39% technology brands 2.91% countries 1.94% finance 0.97% travel destinations 0.97% stocks 0.97% social networks 0.97%
Social topic influence study 9.71%, education #1138, dr 3.88%, supported 3.88%, knowledge 3.88%, in the 3.88%, future 3.88%, key 3.88%, the first 2.91%, what is 2.91%
Top accounts mentioned or mentioned by @jacapdevila @netconnectinfo @ncukcharity @amanchauhanmd @nanets1 @helops79 @profkherrmann @oncbrothers @gicancer @louisdemestier @curenets @drenriquegrande @civesmauro @drangelalamarca @cronajoakim @ncfcancer @talonsogordoa @netcancerday @grupogetne @netespana
Top assets mentioned Spotify Technology (SPOT)
Top Social Posts
Top posts by engagements in the last [--] hours
"Exploring the role of targeted radiopharmaceutical treatment in #NETs Experts discuss PRRT and emerging strategies in #neuroendocrine tumours w/ Dr @helops79 @ProfKHerrmann Moderated by @OncBrothers 📹 Watch the video 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2019777349298839874 https://twitter.com/i/web/status/2019777349298839874"
X Link 2026-02-06T14:17Z [----] followers, [---] engagements
"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺 Video for patients & care partners From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Explore: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter #neuroendocrine https://cor2ed.com/net-connect/programmes/thriving-beyond-ep-nec-diagnosis/"
X Link 2026-02-13T08:13Z [----] followers, [--] engagements
"Thriving beyond an EP-NEC diagnosis: Perspectives on treatment and care 📺 Video for patients & care partners From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation Explore: -EP-NEC in context -The complexity and burden of the disease -The concept of thrivership Endorsed by @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim https://twitter.com/i/web/status/2023007559469150615 https://twitter.com/i/web/status/2023007559469150615"
X Link 2026-02-15T12:12Z [----] followers, 53.1K engagements
"Great sessions this morning @ #ENETS19 on nuclear medicine PRRT and impact on response assessment"
X Link 2019-03-08T14:05Z [----] followers, [--] engagements
"Dr. Elettra Merola and Dr. Kira Oleinikov have summarised highlights of the recent #ENETS19 for you @ @net_connectinfo #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors https://net-connect.info/update-from-enets-2019/ https://net-connect.info/update-from-enets-2019/"
X Link 2019-03-14T18:20Z [----] followers, [--] engagements
"Dr. Francesca Spada provides an overview of #CarcinoidSyndrome on behalf of @net_connectinfo @ #neuroendocrine #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors https://net-connect.info/an-overview-of-carcinoid-syndrome/ https://net-connect.info/an-overview-of-carcinoid-syndrome/"
X Link 2019-05-15T20:16Z [----] followers, [--] engagements
"An interactive discussion on treatment sequencing in advanced digestive NETs. Thanks to the esteemed faculty of Dr. Marianne Pavel Dr. Jaume Capdevila (@Ja_Capdevila) Dr. Louis DeMestier (@louis_demestier) and Dr. Angela Lamarca. Thank you to all attendees for participating"
X Link 2019-09-30T07:11Z [----] followers, [--] engagements
"Understand more about treatment sequencing in advanced digestive NET from a recent @net_connectinfo Experts Knowledge Share with @Ja_Capdevila @louis_demestier Prof Marianne Pavel and Dr Angela Lamarca #NETCancer #NeuroendocrineCancer #oncology visit: https://net-connect.info/net-connect-eks-esmo-2019/ https://net-connect.info/net-connect-eks-esmo-2019/"
X Link 2019-11-06T18:35Z [----] followers, [--] engagements
"@net_connectinfo On NET cancer day proud to raise awareness of NET through our independent medical education programs. #NETCancerDay"
X Link 2019-11-10T21:21Z [----] followers, [--] engagements
"Interested in learning more about practice changing clinical trials in #NeuroendocrineTumors Explore this resource developed by Dr Joakim Crona (@CronaJoakim) on behalf of @net_connectinfo #NETCancer #education #oncology https://net-connect.info/practice-changing-clinical-trials-in-net/ https://net-connect.info/practice-changing-clinical-trials-in-net/"
X Link 2019-11-14T14:25Z [----] followers, [--] engagements
"Learn about Treatment Sequencing in Advanced Digestive NET an accredited e-learning with @net_connectinfo members Prof. Pavel @Ja_Capdevila @louis_demestier and Dr. Angela Lamarca #NETCancer #NeuroendocrineCancer #oncology https://net-connect.info/e-learning-treatment-sequencing-in-advanced-digestive-net/ https://net-connect.info/e-learning-treatment-sequencing-in-advanced-digestive-net/"
X Link 2020-01-27T09:04Z [----] followers, [--] engagements
"Recognising World Cancer Day today and all patients affected by cancer. Continuing to raise awareness and contribute to medical education for neuroendocrine tumours and new treatments. #WCD2020 #oncology #MedEd #NETS"
X Link 2020-02-04T07:36Z [----] followers, [--] engagements
"An update from the first virtual #ENETS20 conference is now available summarised by Dr. Alia Munir and Dr. Mauro Cives on behalf of NET CONNECT. Videos and downloadable slides @ #NETCancer #NeuroendocrineCancer #oncology #MedEd https://net-connect.info/net-connect-update-from-enets-2020/ https://net-connect.info/net-connect-update-from-enets-2020/"
X Link 2020-03-20T17:13Z [----] followers, [--] engagements
"Results of [--] @net_connectinfo studies from #ENETS20 on SSAs in pNETs (Ki-67 10%) Management of advanced digestive G3 NETs & Management of CHD in advanced midgut NET summarised by @T_AlonsoGordoa @louis_demestier & Dr Faidon Laskaratos https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/ https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/"
X Link 2020-05-07T12:44Z [----] followers, [--] engagements
"Interesting early data of nivolumab and temizolomide in advanced NETs. #NET #oncology #MedEd"
X Link 2020-05-20T12:10Z [----] followers, [--] engagements
"Nice NET presentations given during the Improving outcomes for GI cancers symposium today at #WorldGI2020 presented by two #NETCONNECT members @Ja_Capdevila and @louis_demestier. #MedEd #oncology"
X Link 2020-07-02T22:11Z [----] followers, [--] engagements
"Oral NET abstract at #WorldGI2020 on germline mutations in young #NET patients presented by Prof Riechelmann.#MedEd #oncology"
X Link 2020-07-02T22:16Z [----] followers, [--] engagements
"Good selection of NET mini oral sessions at #ESMO20. CLARINET FORTE presentation by Marianne Pavel providing encouraging data on escalating lanreotide dose frequency followed by interesting discussant by Angela Lamarca indicating difficult to compare with studies like NETTER-1"
X Link 2020-09-19T22:46Z [----] followers, [--] engagements
"Small intestine well-differentiated NETs: what is the current practice and rationale for 3rd line treatment after SSA and PRRT Check out the poster presentation of our NET CONNECT members at #ENETS21. #ENETS2021 #NET #MedEd #oncology"
X Link 2021-02-25T16:18Z [----] followers, [--] engagements
"PRRT treatment in #NET: A great overview of improved peptides for PRRT other targets for PRRT new radionuclides and combination therapies with PRRT presented by Prof. Damian Wild during #ENETS21. #ENETS2021 #MedEd #oncology"
X Link 2021-02-26T12:24Z [----] followers, [--] engagements
"Many ongoing clinical trials in Europe North America Asia and Australia. A great overview of this was given by @drenriquegrande NET connect member Emily Bergsland and Jie Chen. #ENETS21 #ENETS2021 #NET #MedEd #oncology"
X Link 2021-02-26T15:23Z [----] followers, [--] engagements
"What is the role of nuclear medicine in the management of NENs Several NET CONNECT members contributed to this international consensus on molecular imaging and theranostics in NENs. @Ja_Capdevila #NET #NETCancer #NeuroEndocrineCancer #MedEd #oncology http://ow.ly/j2qH50DV7Db http://ow.ly/j2qH50DV7Db"
X Link 2021-03-12T11:25Z [----] followers, [--] engagements
"Poster [---] at #AACR21: Important preclinical research by @3amrogram and colleagues on the efficacy of platinum based chemotherapy regimens and targeted therapeutics in a PDX model of mixed acinar neuroendocrine carcinoma of the pancreas (MANEC-P). #MedEd http://ow.ly/XooJ50EozvV http://ow.ly/XooJ50EozvV"
X Link 2021-04-14T21:04Z [----] followers, [--] engagements
"#ASCO21: Results from Halperin et al. from the phase [--] trial with PEN-221 SSA-DM1 conjugate in patients with advanced GI mid-gut NETs showed a clinical benefit rate of 88.5% and a median PFS of [--] months. #NET #MedEd #oncology http://ow.ly/6aUG50F5V13 http://ow.ly/6aUG50F5V13"
X Link 2021-06-08T21:38Z [----] followers, [--] engagements
"At #WorldGI2021 Jonathan Strosberg discussed the results from the NETTER-1 study: Significant improvement in PFS Trend of improvement in median OS (11.7 months) in 177Lu-DOTATATE vs control No new long-term safety signals for MDS and nephrotoxicity #NET #MedEd"
X Link 2021-07-04T22:29Z [----] followers, [--] engagements
"Two sessions on RAI-R differentiated thyroid cancer: 👉 @Ja_Capdevila presented COSMIC-311 showing a superior efficacy of cabozantinib treatment vs. placebo. 👉 Sophie Leboulleux presents results from the MERAIODE trial with trametinib in RAS-mutated patients. #ESMO21 #MedEd"
X Link 2021-09-20T17:04Z [----] followers, [--] engagements
"Wednesday [--] November is World NET Cancer Day a day to increase awareness of #neuroendocrine cancers. On this day ENETS and INCA organise an educational webinar for patients and patient advocates. @netcancerday #LetsTalkAboutNETs #NETCancerDay https://www.enets.org/net-cancer-awareness-day.html https://www.enets.org/net-cancer-awareness-day.html"
X Link 2021-11-09T17:01Z [----] followers, [--] engagements
"Great presentation by @Ja_Capdevila on the efficacy of lanreotide in patients with metastatic BP-NETs (the SPINET study) emphasizing that tumor growth rate (TGR) is a promising exploratory endpoint and should be included in future clinical trials. #ENETS22 #ENETS #MedEd"
X Link 2022-03-10T11:22Z [----] followers, [--] engagements
"Results from the MetNET-2 trial presented by Sara Pusceddu suggest a synergistic activity between lanreotide and metformin which requires further investigation in RCTs. Genomic characterization of #NETs may help elucidate mechanisms underlying this. #ENETS22 #ENETS #MedEd"
X Link 2022-03-10T17:43Z [----] followers, [--] engagements
"Maria del Carmen Riesco-Martinez presented the results from the NICE-NEC study on nivolumab and platinum-doublet chemotherapy in untreated advanced G3 NENs showing a synergistic effect which requires further follow-up and RCTs. @GrupoGetne #ENETS22 #ENETS #MedEd"
X Link 2022-03-11T17:47Z [----] followers, [--] engagements
"What are best treatment sequences in advanced NET In the next #ENETS webinar this will be discussed for lung NET PNET and SiNET by Dieter Hrsch @Ja_Capdevila and @RachelRiechelm2 . #MedEd #NeuroEndocrineTumor http://ow.ly/2VVb50INaML http://ow.ly/2VVb50INaML"
X Link 2022-04-25T08:00Z [----] followers, [--] engagements
"Here is an excellent guide that can help you as a clinician to best approach metastatic #NENs of unknown primary utilising histological assessments and auxiliary analyses of value. NEN-UPs from a pathologists perspective. 👉🏼 #MedEd #LetsTalkAboutNETs http://ow.ly/ORCO50J8Kwz http://ow.ly/ORCO50J8Kwz"
X Link 2022-05-21T19:00Z [----] followers, [--] engagements
"⚡ Results of the Phase [--] #TOPIC-NEC trial published in @JAMAOnc Study finds that both #etoposide plus #cisplatin (EP) or #irinotecan plus cisplatin (IP) remain effective 1L treatments for pts with advanced #NEC of the digestive system. #MedEd http://ow.ly/RXo350KnY5O http://ow.ly/RXo350KnY5O"
X Link 2022-08-22T07:00Z [----] followers, [--] engagements
"Great to hear from @cives_mauro at #ESMO22 on the results of an international NET CONNECT survey looking at the impact of COVID-19 on the management of NETs.coming soon #NET"
X Link 2022-09-12T13:10Z [----] followers, [--] engagements
"📚Explore the world of #NETs Join Dr @Ja_Capdevila & Asst. Prof. @cives_mauro in this insightful micro-learning module & learn to recognise symptoms diagnose accurately & manage effectively. 👉Check it out today: #MedEd https://ow.ly/kXT950PUmV2 https://ow.ly/kXT950PUmV2"
X Link 2023-10-11T09:01Z [----] followers, [---] engagements
"💡Spotlighting the diversity in pancreatic cancers on #PancreaticCancerDay: adenocarcinomas (90%) and the lesser-known pancreatic #NETs. Understanding the difference matters. Explore our educational programme for insights and awareness. #MedEd https://ow.ly/Qhmu50Q766o https://ow.ly/Qhmu50Q766o"
X Link 2023-11-16T10:00Z [----] followers, [---] engagements
"🗣Insightful discussions on #NETs are unfolding at #ESMO2024 in Barcelona We're excited to learn about the latest developments. Follow us to stay in the loop https://x.com/FRANCES88189587/status/1834718750698090504 📣📣📣The best way to start ESMO2024 for neuroendocrine community Amazing session brilliant speakers vibrant discussions. Lovely friends and colleagues and more 🚨CMV-118 in progressive NET 🚨CABONEN in low G3 NEN 🚨NETTER-2 and new insights 🚨Carcinoid heart disease and NET https://t.co/SVuF8pJds6 https://x.com/FRANCES88189587/status/1834718750698090504 📣📣📣The best way to start"
X Link 2024-09-15T04:33Z [----] followers, [---] engagements
"📣 Video podcast 📣 Understanding EP-NEC: Through diagnosis treatment and support w/ Medical Oncologist Dr @AmanChauhanMD + Neuroendocrine Patient Advocate Susan Meckler-Plummer RN 📹 Highlights in this post Watch the full video or listen on Spotify/Apple: 🤝 Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group in your country or region Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #NET #EndoTwitter #LetsTalkAboutNETs"
X Link 2026-02-16T12:42Z [----] followers, [--] engagements
"Dr. Angela Lamarca on behalf of @net_connectinfo discusses the highlights on neuroendocrine tumours presented at #ESMO19 @ #neuroendocrine #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors https://net-connect.info/net-connect-update-from-esmo-2019/ https://net-connect.info/net-connect-update-from-esmo-2019/"
X Link 2019-10-09T09:39Z [----] followers, [--] engagements
"Fantastic start to #ENETS2020 well done to all involved; a great opportunity to collaborate virtually. Looking forward to the next few days"
X Link 2020-03-11T11:29Z [----] followers, [--] engagements
"Interesting presentation on 'Assessing Response to PRRT' today during #ENETS2020. Looking forward to the rest of the day [--] of the ENETS virtual meeting"
X Link 2020-03-12T12:45Z [----] followers, [--] engagements
"Listen to the results of [--] @net_connectinfo studies from #ENETS20 on SSAs in pNETs (Ki-67 10%) Management of advanced digestive G3 NETs & Management of CHD in advanced midgut NET at #NETCancer #NeuroendocrineCancer #oncology #MedEd https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/ https://net-connect.info/net-connect-scientific-projects-presented-at-enets-2020/"
X Link 2020-05-20T16:17Z [----] followers, [--] engagements
"Congratulations to Val DHebron and one of our esteemed NET Connect steering committee: @Ja_Capdevila First center of excellence for NET treatment in Spain. Hospital Universitari Vall dHebron together with VHIO have recently been accredited as Centre of Excellence by ENETS. Congratulations to the whole team @Netespana #LetsTalkAboutNETs https://t.co/k0qiH3qxNU First center of excellence for NET treatment in Spain. Hospital Universitari Vall dHebron together with VHIO have recently been accredited as Centre of Excellence by ENETS. Congratulations to the whole team @Netespana #LetsTalkAboutNETs"
X Link 2020-06-24T15:56Z [----] followers, [--] engagements
"NGS practice patterns Another interesting project being initiated within the NETCONNECT group #NET #Oncology #MedEd t-NET [--] Mitosis/10HPF and Ki67 40%.Morphology intermediate: LCNEC-atypical carcinoid.TMB 23Pt qualifed for our immuno trial.We at @net_connectinfo studying NGS practice pattern in NETs globally. Do u use NGS for NETs/NEC Upfront or Relapse Trials or SOC @pashtoonkasi https://t.co/bKXX0fCWjb t-NET [--] Mitosis/10HPF and Ki67 40%.Morphology intermediate: LCNEC-atypical carcinoid.TMB 23Pt qualifed for our immuno trial.We at @net_connectinfo studying NGS practice pattern in NETs"
X Link 2020-07-12T09:05Z [----] followers, [--] engagements
"DUNE study presented by @Ja_Capdevila #ESMO20 durvalumab+tremelimumab showed only modest activity in a heavily pretreated group of advanced NENs. GEP-NEN cohort data promising #NET #Oncology #MedEd"
X Link 2020-09-20T22:46Z [----] followers, [--] engagements
"On NET cancer day NET CONNECT is proud to play our part in raising awareness of #NET and providing medical education programs in this rare disease area.#MedEd #Onc"
X Link 2020-11-10T06:46Z [----] followers, [--] engagements
"Delighted @net_connectinfo members have had [--] abstracts accepted for poster presentations at #ENETS21. Watch out for abstracts on NGS practice patterns and 3rd line treatment practice for wd-SiNET @T_AlonsoGordoa @louis_demestier @AmanChauhanMD @CronaJoakim #MedEd #Oncology #NET"
X Link 2021-01-13T22:59Z [----] followers, [--] engagements
"Presentation on the first study of circulating progastrin (hPG80) in #NET by NET Connect member @AmanChauhanMD showing hPG80 as a promising biomarker. #ENETS21 #ENETS2021 #Oncology #MedEd"
X Link 2021-02-25T14:58Z [----] followers, [--] engagements
"Great session on Translational Research with two different presentations on the use of organoid models in NEN. @TalyaDalton and Dr. Kenta Kawasaki. #NETs 'ENETS21 #ENETS2021 #Oncology #MedEd"
X Link 2021-02-26T16:54Z [----] followers, [--] engagements
"NET CONNECT member Dr.Angela Lamarca gave an excellent presentation at #ENETS21 today regarding considerations for #NEN patients who have not yet had children or are pregnant. #ENETS2021 #Oncology #MedEd"
X Link 2021-02-27T12:01Z [----] followers, [--] engagements
"Immunotherapy in lung NEN: NET CONNECT member @Ja_Capdevila gave a great overview of immunotherapy in lung NEN and the ongoing clinical trials in this field. #ENETS21 #ENETS2021 #NET #MedEd #oncology"
X Link 2021-02-27T16:27Z [----] followers, [--] engagements
"As presented by @drenriquegrande during #ENETS2021: an overview of ongoing clinical trials in Europe. #NET #NETCancer #NeuroEndocrineCancer #MedEd #oncology https://x.com/ncukcharity/status/1366392977862623234 Clinical Trials - Enrique Grandes whistlestop tour of Europe: https://t.co/D3r1CDABBm listed as recruiting/not yet recruiting : ARTISAN BEVANEC CABATEN CABONEN COMPETE DUNE FOLFIRINEC LUTHREE LOLA MGMT-NET NEONEC NIPINEC SENECA #ENETs2021 https://x.com/ncukcharity/status/1366392977862623234 Clinical Trials - Enrique Grandes whistlestop tour of Europe: https://t.co/D3r1CDABBm listed as"
X Link 2021-03-09T10:29Z [----] followers, [--] engagements
"On March 28th NET CONNECT member @AmanChauhanMD will give a presentation at the Advances in Gastrointestinal Cancer International Conference and talk about #PRRT in #NETs. #NETCancer #MedEd #oncology https://x.com/btfoundation/status/1372589866525941761 We are holding our virtual #GIcancer #GISM conference for #CME on March [--] Attend to hear talks on recent clinical advancements from national and global experts including @SirohiBhawna @AmanChauhanMD @DocCatenacci and more Register to attend at https://t.co/Dfhvujkx3D https://t.co/LRzh1Kw3Xi"
X Link 2021-03-24T11:38Z [----] followers, [--] engagements
"Poster [---] at #AACR21: NET CONNECT member @AmanChauhanMD and colleagues present the phase [--] trial of triapine and Lutetium Lu [---] Dotatate in combination for well-differentiated somatostatin receptor-positive GEP-NETs. #NET #NETCancer #MedEd #oncology https://x.com/NCICTEP_ClinRes/status/1380856855593938952 https://x.com/NCICTEP_ClinRes/status/1380856855593938952"
X Link 2021-04-11T15:51Z [----] followers, [--] engagements
"Great work by @Ja_Capdevila and colleagues on the TALENT phase II trial showing very promising results for the use of lenvatinib in advanced GEP-NETs. #NET #NETCancer #MedEd https://x.com/Ja_Capdevila/status/1389861184942313479 TALENT study publication arrives on May the 4th 🌟😬💪🏼One of the highest response rate ever seen in #NeuroendocrineCancer with an MKI @drenriquegrande @JHernando3 @PaulaJFonseca @xavimerino @lorenatrejo91 @GrupoGetne @Netespana @VHIO @_SEOM @vallhebron https://t.co/Ouu3veJl2n https://x.com/Ja_Capdevila/status/1389861184942313479 TALENT study publication arrives on"
X Link 2021-05-05T10:41Z [----] followers, [--] engagements
"#ASCO21: The NETTER-1 study shows positive final results on PFS after 177Lu-DOTATATE treatment in #NET. To aid consideration of #PRRT with 177Lu-DOTATATE @nanudasmd and colleagues developed and validated a clinical score. http://ow.ly/qeOI50F3WL8 http://ow.ly/OEOp50F3NHc http://ow.ly/qeOI50F3WL8 http://ow.ly/OEOp50F3NHc"
X Link 2021-06-06T16:55Z [----] followers, [--] engagements
"A recent publication by NET CONNECT steering committee member Prof. Kjell berg and his colleagues showed that a multigenomic blood biomarker (#NETest) effectively diagnoses #NETs and outperforms CgA. #NeuroEndocrineTumors #MedEd https://x.com/myESMO/status/1427662076391133192 A blood-based #multigenomic signature is an effective diagnostic & has clinical utility in #NET mgmt: the 51-gene expression-based #liquidbiopsy accurately diagnoses #neuroendocrinetumours & is an effective surrogate marker compared to chromogranin A https://t.co/iq1Z4vTIpG https://t.co/VX7OtB4YFr"
X Link 2021-08-19T11:58Z [----] followers, [--] engagements
"Podcast now available Listen to Dr Jaume Capdevila @Ja_Capdevila and Dr Rachel van Leeuwaarde discuss Optimal Management of #DifferentiatedThyroidCancer with VEGFR-TKIs (MKIs) #thyroidcancerawarenessmonth #ThyCa Access the podcast here https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/ https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/"
X Link 2021-09-09T10:35Z [----] followers, [--] engagements
"Listen to our podcast with Dr Jaume Capdevila @Ja_Capdevila and Dr Rachel van Leeuwaarde talking about Optimal Management of #DifferentiatedThyroidCancer with VEGFR-TKIs (MKIs) #ThyCa Access the podcast here https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/ https://net-connect.info/podcast-optimising-vegfr-tkis-mkis-in-differentiated-thyroid-cancer/"
X Link 2021-10-05T20:25Z [----] followers, [--] engagements
"With #ASCO2022 just around the corner we will be providing social media coverage on the most important developments in #NET. Tag along as Dr. @PamelaKunzMD presents the final efficacy analysis of #MGMT as a predictive biomarker on June [--] 14:48 BST. http://ow.ly/NHbc50Jk9Wx http://ow.ly/NHbc50Jk9Wx"
X Link 2022-05-30T11:00Z [----] followers, [--] engagements
"Which patients to treat and when to start PRRT therapy in #NETs This review article @JCO_ASCO provides guidance on patient selection and treatment strategy using #PRRT. Great to see our experts Dr. Marianne Pavel and Dr. Emily Bergsland as authors http://ow.ly/XwEM50JNKhj http://ow.ly/XwEM50JNKhj"
X Link 2022-07-05T08:00Z [----] followers, [--] engagements
"Effects of the COVID-19 pandemic on NET management published in @JNE_Editor. Thanks to the authors @cives_mauro @JHernando3 @DrAngelaLamarca Catherine Bouvier Ellis @ncukcharity @Prof_M_C Prof Pavel. Thanks also to INCA & @NANETS1 #LetsTalkAboutNETs https://cor2ed.com/net-connect/programmes/international-net-covid-19-survey-published-in-journal-of-neuroendocrinology/ https://cor2ed.com/net-connect/programmes/international-net-covid-19-survey-published-in-journal-of-neuroendocrinology/"
X Link 2022-10-17T14:34Z [----] followers, [---] engagements
"Delighted to announce we have launched the #NET micro e-learning on the role of SSA at progression developed by Prof. Caplin & @AmanChauhanMD 🔴slides flashcard & podcast available 🔴test your knowledge with the assessment 🔴accredited course #MedEd http://ow.ly/vwK850M6OQp http://ow.ly/vwK850M6OQp"
X Link 2022-12-20T16:23Z [----] followers, 836.7K engagements
"📅The first #ENETS webinar of [----] will take place on [--] Jan this time moderated by our @net_connectinfo expert @DrAngelaLamarca Topic: Where do we stand in #NET #NEC #PPGL #MTC & #MCC 👉🏼 #MedEd http://ow.ly/OSYi50MkVAT http://ow.ly/OSYi50MkVAT"
X Link 2023-01-17T08:50Z [----] followers, [----] engagements
"Exciting news Our microlearning on how to recognize diagnose and manage NETs developed by @Ja_Capdevila and @cives_mauro is live Access the video flashcard and slide deck from the link below: https://cor2ed.com/net-connect/programmes/managing-neuroendocrine-tumours/ https://cor2ed.com/net-connect/programmes/managing-neuroendocrine-tumours/"
X Link 2023-08-30T10:13Z [----] followers, 505.5K engagements
"🎧 Did you tune into the podcast with Prof. Martyn Caplin & Dr Aman Chauhan They discuss the role of SSAs in #NETs at progression sharing their own experience and clinical practice. Listen on your preferred podcast platform: Spotify: Apple: COR2ED Website: Don't miss it #MedEd https://shorturl.at/ehjD7 https://shorturl.at/sFOW9 https://shorturl.at/dpNV6 https://shorturl.at/ehjD7 https://shorturl.at/sFOW9 https://shorturl.at/dpNV6"
X Link 2023-09-18T14:26Z [----] followers, 681K engagements
"🚨⚡New guidelines for management of #NF-Pan-NET published Specialists worked together to answer [--] troublesome clinical questions such as: 💡What is the role of PRRT in pts w/ NF-Pan-NET 💡What is the recommended follow-up in NF-Pan-NET pts https://ow.ly/VVje50Q5Yrk https://ow.ly/VVje50Q5Yrk"
X Link 2023-11-10T11:54Z [----] followers, [---] engagements
"💡On #NETCancerDay let's amplify the importance of independent medical education in understanding & addressing #NETs. Knowledge empowers & today we unite for awareness support & continued education to improve outcomes for NET patients. Follow us for more #MedEd content"
X Link 2023-11-10T11:55Z [----] followers, [---] engagements
"A retrospective analysis on #PRRT for #NET reveals extending treatment beyond the standard [--] cycles may offer a safe & effective strategy. 📊 More cycles linked to better overall survival (72.8 months vs. [----] months) & disease-specific survival. #MedEd https://ow.ly/Ll4o50QgiPX https://ow.ly/Ll4o50QgiPX"
X Link 2023-12-11T14:50Z [----] followers, [----] engagements
"New study explores therapeutic options for high-grade #GEP-NENs using patient-derived tumoroids. 📊Findings reveal their ability to mirror clinical responses to chemotherapy ex vivo potentially advancing personalised treatment options. #MedEd https://ow.ly/fJtY50QKzVp https://ow.ly/fJtY50QKzVp"
X Link 2024-03-08T09:01Z [----] followers, [---] engagements
"Exciting news from #ESMOSarcomaCongress2024: Lurbinectedin & irinotecan combo demonstrates synergy in pre-treated Grade [--] GEP-NECs Phase II study reports ORR of 15% DCR of 60% median PFS of [---] months & OS at [--] months of 45.0%. #MedEd https://ow.ly/e0gY50QVc2E https://ow.ly/e0gY50QVc2E"
X Link 2024-03-18T07:04Z [----] followers, [----] engagements
"Tumour size (2cm) & grade (G2 G3) emerge as significant risk factors for lymph node metastasis in #NETs and should be considered when selecting a treatment option for radical resection with #LN dissection for rectal NETs a recent study reports. https://ow.ly/RJmM50RjKKq https://ow.ly/RJmM50RjKKq"
X Link 2024-04-22T16:03Z [----] followers, [----] engagements
"Brand new podcast series on #neuroendocrinetumours. Listen to Prof. Martyn Caplin & Prof. Rachel Riechelmann discuss NET epidemiology diagnosis and referral strategies Episode [--] Apple YouTube #MedEd #LetsTalkAboutNETs https://youtu.be/6fKAxS4u-2osi=uEkqMSEfDjXa5s8m https://podcasts.apple.com/podcast/cor2ed-medical-education/idid1719836050i=1000657036427 https://open.spotify.com/episode/3CB3fTp7vxQOHG9XvMSwYO https://cor2ed.com/net-connect/programmes/regional-differences-neuroendocrine-tumours-nets-1/ https://youtu.be/6fKAxS4u-2osi=uEkqMSEfDjXa5s8m"
X Link 2024-06-10T12:26Z [----] followers, 393.2K engagements
"🔬DOTATATE-PET CT for #GEP-NETs: Larger tumours (2 cm) higher CgA levels (150 ng/mL) and higher tumour grades (G2) are significant predictors. Tumour size OR: [-----] (P0.001) CgA OR: [----] (P=0.005) grade G2 OR: [---] (P0.001). #MedEd https://ow.ly/MpeM50SnV1o https://ow.ly/MpeM50SnV1o"
X Link 2024-06-24T08:04Z [----] followers, [---] engagements
"💡New scoping review investigates #PRRT as neoadjuvant therapy in #NeuroendocrineNeoplasms. Limited evidence suggests potential role in enhancing resectability yet high-quality studies are needed to confirm benefits and optimize protocols. #MedEd https://ow.ly/uEUx50Sss5j https://ow.ly/uEUx50Sss5j"
X Link 2024-07-03T08:01Z [----] followers, [---] engagements
"🌍🔬 The [----] ENETS guidance paper for managing well-differentiated small intestine neuroendocrine tumours (#Si-NET) is out It emphasises the importance of adequate biochemical assessment staging and multidisciplinary treatment decisions. #MedEd https://ow.ly/USu150Syga9 https://ow.ly/USu150Syga9"
X Link 2024-07-10T03:44Z [----] followers, [---] engagements
"🔬 PRRT shows promise for high-grade digestive NENs including #NET G3 with strong PFS benefits in recent studies like NETTER-2. Could this be a 1st-line option For NEC evidence is limited but PRRT may be considered in select cases. #MedEd https://ow.ly/par850TjO8Z https://ow.ly/par850TjO8Z"
X Link 2024-09-10T09:29Z [----] followers, [----] engagements
"📊 In the LUTADOSE study tumour dosimetry after 1st administration of 177Lu-DOTATATE had prognostic value in patients with G1-G2 GEP NETs. Higher GTD after cycle [--] (10.6 Gy) correlated with longer PFS (median [----] vs. [--] months) #MedEd https://ow.ly/KOJY50TjQWZ https://ow.ly/KOJY50TjQWZ"
X Link 2024-09-12T08:01Z [----] followers, [---] engagements
"#ESMO24 I ABS1148MO 🔥📊NETTER-2 update: 177Lu-DOTATATE + octreotide 30mg LAR shows PFS HR [-----] (95% CI: 0.134-0.337) vs high-dose octreotide (0.276) ORR odds ratio [-----] (95% CI: 3.98-27.29) vs [----]. No new safety concerns. Is this a new standard of care #MedEd"
X Link 2024-09-15T04:44Z [----] followers, [---] engagements
"🔥 New guidelines Managing rare endocrine tumours such as #neuroendocrine neoplasms & parathyroid carcinoma from diagnosis to follow-up. Expert insights from global experts including @net_connectinfo Member @DrAngelaLamarca #MedEd https://x.com/myESMO/status/1841045187176411420 📣 New ESMO #ClinicalPracticeGuideline on Rare #EndocrineTumors: Evidence-based recommendations on imaging diagnosis treatment & follow-up of neuroendocrine parathyroid and intrathyroid thymic neoplasms by experts across Europe. #RareTumors 🔗 https://t.co/c3lFb7icrX https://t.co/cwVyf4wGEM"
X Link 2024-10-07T11:59Z [----] followers, [---] engagements
"New practice guideline alert📢 #Si-NET cases are rising often found late. This new guidance paper from @net_connectinfo Expert @DrAngelaLamarca covers key points on diagnosis staging and treatment in specialised centres. Read more: #MedEd https://ow.ly/wYvj50TN9Iz https://ow.ly/wYvj50TN9Iz"
X Link 2024-10-18T08:00Z [----] followers, [---] engagements
"Did you catch our recent podcast series In Ep.1 Dr Mohid Khan & patient advocate Sally Jenkins discuss shared decision-making and in Ep. [--] they explore how to individualise treatment decisions for better patient outcomes. #LetsTalkAboutNETs Take a look at the highlights📹 Full video at 👉 Supported by an #IME grant from Ipsen #MedEd https://cor2ed.com/net-connect/programmes/net-shared-decision-making/ https://cor2ed.com/net-connect/programmes/net-shared-decision-making/"
X Link 2025-02-06T22:58Z [----] followers, 459.9K engagements
"Now available Explore the evolving role of PRRT in NETs Tap to enlarge the infographic📜 Optimising treatment strategies needs an understanding of the clinical trial data and how studies differ View the infographic to differentiate between key clinical studies including COMPETE & NETTER-1 and [---] to help you pair the right patient with the right treatment From Dr @helops79 @ProfKHerrmann @OncBrothers Endorsers: @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM"
X Link 2025-10-06T08:00Z [----] followers, 148.1K engagements
"Dr. Aman Chauhan @AmanChauhanMD (on behalf of @net_connectinfo) provides highlights on neuroendocrine tumours presented at #ASCO19 and #AACR19 @ #neuroendocrine #NETCancer #NeuroendocrineCancer #NeuroendocrineTumors http://bit.ly/2RbtxXz http://bit.ly/2RbtxXz"
X Link 2019-06-12T15:44Z [----] followers, [--] engagements
"Lanreotide [---] mg every [--] weeks shows promising PFS in midgut #NETs and panNETs. Great presentation by ENETS Chair and NET Connect member Prof. Marianne Pavel. #ENETS [----] #ENETS [----] #MedEd #Oncology"
X Link 2021-02-25T14:51Z [----] followers, [--] engagements
"The next #ENETS webinar will discuss the "post-OMICS" landscape and agnostic strategy in #NET and will be moderated by @drenriquegrande NET CONNECT member @CronaJoakim and @JustoCastano. Wednesday [--] November 18:00-19:40 CEST #MedEd #Oncology http://ow.ly/k1EI50GSOeZ http://ow.ly/k1EI50GSOeZ"
X Link 2021-11-22T14:00Z [----] followers, [--] engagements
"Knowing your patients symptoms can save their lives #LetsTalkAboutNETs #MedEd #NETs https://x.com/ncukcharity/status/1565256975486705664 For #GPs Could it be Neuroendocrine Cancer If you have patients returning with unresolved and / or increasing symptoms Neuroendocrine Cancer may be worth considering: @rcgp @UKINETS https://t.co/MqLJeyymy6 https://x.com/ncukcharity/status/1565256975486705664 For #GPs Could it be Neuroendocrine Cancer If you have patients returning with unresolved and / or increasing symptoms Neuroendocrine Cancer may be worth considering: @rcgp @UKINETS"
X Link 2022-09-04T10:16Z [----] followers, [--] engagements
"🎙New episode of our PODCAST 🎙 Listen to Prof. Martyn Caplin & Dr Aman Chauhan @AmanChauhanMD as they discuss the role of SSAs in #NETs at progression sharing their clinical experience and their own practice Tune in learn and share: #MedEd https://cor2ed.com/net-connect/programmes/podcast-the-role-of-ssa-at-progression-to-continue-or-not/ https://cor2ed.com/net-connect/programmes/podcast-the-role-of-ssa-at-progression-to-continue-or-not/"
X Link 2022-11-22T14:57Z [----] followers, [--] engagements
"Global #SCAN survey of #NET pts finds among [----] pts in [----] 44% were misdiagnosed & the mean years to correct diagnosis is [---] years Enhancing #HCP knowledge & effective diagnostics are key to improved pts survival & #NET care worldwide. #MedEd https://ow.ly/gVZP50OZFqb https://ow.ly/gVZP50OZFqb"
X Link 2023-07-04T08:00Z [----] followers, [----] engagements
"🚨New ASCO Guidelines have been published ASCO's Expert Panel has developed comprehensive recommendations for systemic therapy in metastatic #GEP-NETs. Discover the latest insights and strategies for patient care. #MedED https://ow.ly/WQUi50PRGKb https://ow.ly/WQUi50PRGKb"
X Link 2023-10-02T07:43Z [----] followers, [----] engagements
"👏 NET CONNECT expert @louis_demestier shared invaluable insights on Familial Midgut Neuroendocrine Tumors (#FM-NETs) at #ENETS2024 https://x.com/JHernando3/status/1767891925519007993s=20 @louis_demestier presents data regarding familial midgut NETs. An interesting entity probably under-suspected in our clinical practice. Molecular testing still ongoing. #ENETS24 #ENETS2024 🦓🦓🦓 https://t.co/uyS2oxy6N5 https://x.com/JHernando3/status/1767891925519007993s=20 @louis_demestier presents data regarding familial midgut NETs. An interesting entity probably under-suspected in our clinical practice."
X Link 2024-03-14T08:04Z [----] followers, [---] engagements
"Update for advanced NET patients with 177Lu-DOTATATE retreatment 📊 Median PFS: [----] mos post-initial; [---] mos post-retreatment. Median OS: [----] mos post-initial; [----] mos post-retreatment. 35% showed partial response initially; 23% post-retreatment. https://ow.ly/LVOB50R0UaT https://ow.ly/LVOB50R0UaT"
X Link 2024-03-25T10:46Z [----] followers, [----] engagements
"🔥It's out now 📺Dive into our free #MedED resource created with Prof. Emily Bergsland & Asst Prof. Louis de Mestier with tools for optimising advanced #NETs treatment & management. Explore key tumour patient and treatment factors. Check it out now https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/ https://cor2ed.com/net-connect/programmes/treatment-management-advanced-nets/"
X Link 2024-07-31T14:51Z [----] followers, 672.3K engagements
"New podcast Expert perspectives on PRRT and emerging strategies in NETs 📹 Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE mgmt future directions & more w/ Dr @helops79 @ProfKHerrmann @OncBrothers Endorsed by @NANETS1 CommNETs (@GICancer)@ncukcharity Supported by an Independent Educational Grant from ITM"
X Link 2025-10-02T21:21Z [----] followers, 1.9M engagements
"Raising awareness for World Neuroendocrine Cancer Day Understanding EP-NEC: Through diagnosis treatment and support What do the differences between NETs and NECs mean for patients Poorly differentiated high-grade aggressive cancers need urgent treatment options. Find out more in this video podcast w/ Medical Oncologist Dr @AmanChauhanMD & Neuroendocrine Patient Advocate Susan Meckler-Plummer RN 📹 Highlights in this post Endorsed by Minkahz NETs Mission @ncukcharity @NCFCancer and @CureNETs For more information or support please speak with an HCP or reach out to a local patient advocacy group"
X Link 2025-11-11T09:16Z [----] followers, 373.2K engagements
"NETs: Understanding key clinical studies like COMPETE and NETTER-1 and [---] helps you pair the right patient with the right treatment ✅ What else do you need to know about radiopharmaceutical treatment for #NETs Experts discuss management strategies future directions and more 📹 Video from Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter"
X Link 2025-10-17T12:24Z [----] followers, [----] engagements
"Expert perspectives on PRRT and emerging strategies in #neuroendocrine tumours Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE mgmt future directions & more Here's a short video teaser. see the full video & find out more Supported by an Independent Educational Grant from ITM #MedEd https://cor2ed.com/net-connect/programmes/targeted-radiopharmaceutical-treatment-nets/media=0 https://cor2ed.com/net-connect/programmes/targeted-radiopharmaceutical-treatment-nets/media=0"
X Link 2025-10-21T09:50Z [----] followers, [---] engagements
"Exploring the role of targeted radiopharmaceutical treatment in #NETs Experts discuss PRRT and emerging strategies in #neuroendocrine tumours w/ Dr @helops79 @ProfKHerrmann Moderated by @OncBrothers 📹 Watch the video 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter"
X Link 2025-11-28T13:27Z [----] followers, [--] engagements
"Navigating extrapulmonary neuroendocrine carcinoma (EP-NEC) Insights for patients and care partners 📺 Video in this post Get the key takeaways: 🤝Endorsed by: INCA (@netcancerday) @NECancerAus @ncukcharity @NCFCancer @CureNETs & Minkahz NETs Mission Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #PatientEducation https://cor2ed.com/net-connect/programmes/extrapulmonary-neuroendocrine-carcinoma-ep-nec/media=0 https://cor2ed.com/net-connect/programmes/extrapulmonary-neuroendocrine-carcinoma-ep-nec/media=0"
X Link 2025-12-12T12:29Z [----] followers, [--] engagements
"Check out our recent #NETs video 📹 Expert perspectives on PRRT and emerging strategies in #neuroendocrine tumours - Explore diagnostic strategies pt selection based on clinical trials safety profiles/AE mgmt future directions & more w/ Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter"
X Link 2025-12-12T14:12Z [----] followers, [---] engagements
"NETs: Understanding key clinical studies like COMPETE and NETTER-1 and [---] helps you pair the right patient with the right treatment ✅ What else do you need to know about radiopharmaceutical treatment for #NETs Experts discuss management strategies future directions and more 📹 Video from Dr @helops79 @ProfKHerrmann @OncBrothers 🤝 Endorsed by @NANETS1 CommNETs (@GICancer) & @ncukcharity Supported by an Independent Educational Grant from ITM #MedEd #OncTwitter #MedTwitter #EndoTwitter https://twitter.com/i/web/status/2009539388330680504 https://twitter.com/i/web/status/2009539388330680504"
X Link 2026-01-09T08:15Z [----] followers, [--] engagements
"➡ EP-NEC patients require expert care from specialists knowledgeable in #neuroendocrine carcinoma ➡ Generic care is insufficient to address the aggressive nature and unique challenges of this disease What else do HCPs need to know to support pts w/ extrapulmonary neuroendocrine carcinoma 📺 Watch the video to find out From Jessica Thomas Director of Patient Education at the Neuroendocrine Tumor Research Foundation 🤝 Endorsed by @CureNETs & Minkahz NETs Mission See more of this programme: Supported by an Independent Educational Grant from Boehringer Ingelheim #MedEd #OncTwitter"
X Link 2026-01-09T17:09Z [----] followers, [--] engagements
"There remains an unmet treatment need for extra-pulmonary neuroendocrine carcinomas but emerging clinical data with DLL3-targeted agents are promising. Alongside treatment advances access to strong support networks remains vital for patients and their care partners. Listen along in this Podcast with Medical Oncologist Dr Aman Chauhan and Patient Advocate Susan Meckler-Plummer to learn more: Spotify: Apple Podcasts: This educational programme is supported by an Independent Educational Grant from Boehringer Ingelheim"
X Link 2026-01-12T14:24Z [----] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing